Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

NCT03896685 is registered in ClinicalTrials.gov with Médecins Sans Frontières, France as lead sponsor.

NCT NCT03896685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03896685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
Lead sponsor
Médecins Sans Frontières, France
Phase
Phase 3
Overall status
Completed
Start date
April 6, 2020
Completion date
December 31, 2024
Enrollment
323 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, gram-positive bacterial infections, mycobacterial infections, pulmonary tuberculoses, tuberculosis, tuberculosis, multidrug-resistant